ArticleAmerican health & drug benefits2015
Anticipated Impact of Generic Imatinib Market Entry on the Costs of Tyrosine Kinase Inhibitors.
Lisa M Bloudek et al.PubMed ↗Full text ↗
No numbers read from the abstract.
5 papers cite it
this paperpooled itcites it